Parkinson Disease
Research
Parkinson disease ranks as the second-most common neurological disease, with over 8.5 million different patients diagnosed. With a cause still unknown, and severely underfunded Parkinson Research labs; NeuroSphereG20 is dedicated to raising funds to support current and future research.
Medication
The United States average annual cost for medication alone is estimated to be around $2,500 for Parkinson Disease.
DBS
Treatment devices such as Deep Brain Stimulation is estimated to be around $21,000 to $25,000.
Incremental
Parkinson Disease average Incremental costs total range from $8,000 to $10,000.
The average age for most Parkinson patients is around 60 years. With the retiring age beginning at 62 years old, most families and individuals are financially unprepared for the financial costs of treatment.
NeuroSphereG20 works closely together with team boards, and the help of the community to collect funds to raise money for lower income families and individuals for treatment.